| Revenue growth | FY26 revenue up 17% YoY; Q4 revenue up 22% YoY. |
|---|---|
| Margins | EBITDA margins stable at 31%; PAT margin improved to 23%. |
| Demand visibility | Strong demand in Human Healthcare; US market remains challenging but steady. |
| Management confidence | Balanced confidence despite highlighting significant global geopolitical and inflationary headwinds. |
Growth
FY26 revenue grew 17% YoY. Q4 revenue surged 22% YoY, primarily volume-led by the Human Healthcare and Specialized Manufacturing segments.
Outlook
Targeting steady double-digit growth in FY27. R&D center in Nashik becomes fully operational in H2 FY27.
Risks
Inflation in fuel, salt, and solvents; high US market competition; and potential margin compression from rising input costs.
Earnings Call filed with BSE, NSE: ADVENZYMES. Summary written with AI assistance from the document.
Advanced Enzyme Technologies Ltd: key numbers
- Share price
- ₹291.15
- Market cap
- ₹3,260 Cr
- Revenue (annual)
- ₹745.8 Cr
- Net profit (annual)
- ₹168.7 Cr
- P/E (TTM)
- 19.6×Sector 50.4×
- Promoter holding
- 43.24%-0.02% QoQ
- FII holding
- 26.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advanced Enzyme Technologies Ltd
All →Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies Ltd bought back 50,000 equity shares on September 25, 2026. This transaction was executed at an average price of ₹295.80 per share.
- Value
- ₹1.48 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 64,668 shares on September 24, 2026, at an average price of ₹298.0272 per share.
- Value
- ₹1.93 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 63,616 shares at an average price of ₹297.47. The total value of today's buyback transaction is ₹1.89 Crore.
- Value
- ₹1.89 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies Ltd repurchased 1,136 equity shares on September 22, 2026, at an average price of ₹295.90. This daily filing is for compliance.
- Value
- ₹0.03 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 50,000 equity shares on September 21, 2026, at an average price of ₹289.49 per share.
- Value
- ₹1.45 Cr
Advanced Enzyme Technologies Promoter Reclassification
Advanced Enzyme Technologies received requests from four promoter group members to reclassify as 'Public' shareholders. These requests are pending board consideration.